[
    [
        {
            "time": "",
            "original_text": "贝达药业(300558.SZ)：股东YINXIANGWANG减持期届满累计减持214.38万股 减持股份",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "YINXIANGWANG",
                    "减持",
                    "届满",
                    "214.38万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：股东YINXIANGWANG减持期届满累计减持214.38万股 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "贝达药业：股东减持0.53%股份，减持计划期间届满 拟减持股份",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "减持",
                    "0.53%",
                    "届满",
                    "拟减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝达药业：股东减持0.53%股份，减持计划期间届满 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]